Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Blood (2022) 140 (Supplement 1): 2302–2305.

https://doi.org/10.1182/blood-2022-165217

Published: 2022

Journal Articles

Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roos Weil, Alix Baugier de Materre, Xavier Roussel, Sabine Tricot, Jehan Dupuis, Ronan Le Calloch, Benoit Bareau, Marie C Béné, Veronique Leblond

Blood (2022) 140 (Supplement 1): 3627–3628.

https://doi.org/10.1182/blood-2022-157394

Published: 2022

Journal Articles

Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2 rearrangement

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-139210

Published: 2020

Journal Articles

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-139224

Published: 2020

Journal Articles

The Bendamustine Plus Rituximab Regimen Is Active and Safe in Previously Untreated Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Kamel Laribi, Stéphanie Poulain, MD, Lise Willems, MD, Fatiha Merabet, Charles Herbaux, Damien Roos-Weil, Alix Baugier de Materre, Xavier Roussel, Sabine Tricot, Jehan Dupuis, MD, Ronan Le Calloch, Benoit Bareau, Marie C Bene, PharmD,DPhil, Veronique Leblond

Blood (2017) 130 (Supplement 1): 4046.

https://doi.org/10.1182/blood.V130.Suppl_1.4046.4046

Published: 2017

Journal Articles

TP53 Mutation in Waldenstrom Macroglobulinemia

Stephanie Poulain, Christophe Roumier, MD, Elisabeth Bertrand, Aline Renneville, MD, Sabine Tricot, Aurelie Caillault Venet, Sandrine Geffroy, PhD, Morgan Nudel, Charles Herbaux, MD, Stéphanie Guidez, Claude Preudhomme, MD PhD, Xavier Leleu

Blood (2016) 128 (22): 4092.

https://doi.org/10.1182/blood.V128.22.4092.4092

Published: 2016

Journal Articles

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Blood (2015) 126 (23): 1505.

https://doi.org/10.1182/blood.V126.23.1505.1505

Published: 2015

Journal Articles

Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

Eileen Boyle, Guillemette Fouquet, Julie Lejeune, Salomon Manier, MD, Lucile Musset, Claire Bories, Remy Dulery, MD, Stéphanie Guidez, Sarah Bonnet, Brigitte Onraed, Jean-Luc Faucompre, Sabine Tricot, Stephanie Poulain, Veronique Leblond, MD PhD, Kym Snell, Xavier Leleu, MD

Blood (2015) 126 (23): 3042.

https://doi.org/10.1182/blood.V126.23.3042.3042

Published: 2015

Journal Articles

Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques

Eileen M Boyle, MD, Julie Lejeune, Salomon Manier, MD, Lucile Musset, MD, Claire Bories, MD, Remy Dulery, Stéphanie Guidez, Sarah Bonnet, MD, Guillemette Fouquet, MD, Brigitte Onraed, MD, Jean-Luc Faucompré, MD, Sabine Tricot, MD, Stephanie Poulain, Veronique Leblond, MD PhD, Xavier Leleu, MD, Stephen Harding, PhD

Blood (2014) 124 (21): 2978.

https://doi.org/10.1182/blood.V124.21.2978.2978

Published: 2014

Journal Articles

Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia

Stephanie Poulain, Christophe Roumier, Emmanuelle Doye, Martin Figeac, Aurélie Caillault, Sandrine Geffroy, Olivier Nibourel, PhD, Frederic Lepretre, Agnes Daudignon, Sabine Tricot, MD, Patrick Duthilleul, Claude Preudhomme, PharmD, PhD, Xavier Leleu, MD

Blood (2014) 124 (21): 1627.

https://doi.org/10.1182/blood.V124.21.1627.1627

Published: 2014

Journal Articles

MYD88 L265P mutation in Waldenstrom macroglobulinemia

Stéphanie Poulain, Christophe Roumier, Audrey Decambron, Aline Renneville, Charles Herbaux, Elisabeth Bertrand, Sabine Tricot, Agnès Daudignon, Sylvie Galiègue-Zouitina, Valerie Soenen, Olivier Theisen, Nathalie Grardel, Olivier Nibourel, Catherine Roche-Lestienne, Bruno Quesnel, Patrick Duthilleul, Claude Preudhomme, Xavier Leleu

Blood (2013) 121 (22): 4504–4511.

https://doi.org/10.1182/blood-2012-06-436329

Published: 2013

Journal Articles

Genome Wide SNP Array (SNPa) Analysis Reveals Clonal Evolution During Clinical Course in Waldenstrom's Macroglobulinemia (WM)

Stephanie Poulain, Christophe Roumier, Charles Herbaux, MD, Aline Renneville, MD, Elisabeth Bertrand, Agnes Daudignon, Sabine Tricot, MD, Valérie Soenen, Catherine Roche-Lestienne, Olivier Nibourel, Bruno Quesnel, MD, PhD, Claude Preudhomme, Patrick Duthilleul, Xavier Leleu, MD

Blood (2012) 120 (21): 297.

https://doi.org/10.1182/blood.V120.21.297.297

Published: 2012

Journal Articles

MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia

Stephanie Poulain, Christophe Roumier, Audrey Decambron, Aline Renneville, MD, Charles Herbaux, MD, Elisabeth Bertrand, Sabine Tricot, MD, Agnes Daudignon, Sylvie Galiegue-Zouitina, Olivier Theisen, Nathalie Grardel, Valérie Soenen, Olivier Nibourel, Catherine Roche-Lestienne, Bruno Quesnel, Patrick Duthilleul, Claude Preudhomme, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 1307.

https://doi.org/10.1182/blood.V120.21.1307.1307

Published: 2012

Journal Articles

B-Cell-Specific Transcription Factor BACH2 Involved in the Clinical Behavior Heterogeneity of Waldenström Macroglobulinemia

Charles Herbaux, MD, Guillemette Marot, Elisabeth Bertrand, Natacha Broucqsault, Sylvie Zouitna-Galiègue, Christophe Roumier, Nicolas Poret, Valérie Soenen, Olivier Nibourel, Catherine Roche-Lestienne, Aline Renneville, Eileen Boyle, Guillemette Fouquet, MD, Sabine Tricot, MD, Claude Preudhomme, Bruno Quesnel, MD, PhD, Stephanie Poulain, Xavier Leleu, MD, PhD

Blood (2012) 120 (21): 1288.

https://doi.org/10.1182/blood.V120.21.1288.1288

Published: 2012

Journal Articles

90-Yttrium Ibritumomab Tiuxetan (Zevalin) and BEAM Chemotherapy (Z-BEAM) Vs BEAM for Autologous Stem Cell Transplantation in Lymphoma: Toxicity and Long Term Outcome From a Retrospective Multicentric Study of 123 Patients.

Louis Terriou, MD, Hanane Gasmi, Salomon Manier, MD, Isabelle Plantier, MD, Marc Wetterwald, MD, PhD, Pauline lionne-Huyghe, MD, Daniela Robu, MD, Sabine Tricot, MD, Ibrahim Yakoub-Agha, MD, PhD, Nicolas Simon, PhD, Pascal Odou, PhD, Franck Morschhauser, MD, PhD

Blood (2012) 120 (21): 2726.

https://doi.org/10.1182/blood.V120.21.2726.2726

Published: 2012

Journal Articles

Hevylite, a Novel M-Component Based Biomarkers of Response to Therapy and Survival in Waldenstrom Macroglobulinemia

Salomon Manier, MD, Julie Lejeune, Lucile Musset, MD, Eileen Boyle, MD, Remy Dulery, MD, Houria Debarri, MD, Jean-Luc Faucompret, Jordan Gauthier, MD, Claire Bories, MD, Guillemette Fouquet, MD, Charles Herbaux, MD, Sabine Tricot, MD, Annie Pietrantuono, MD, Frederic Combat, MD, Stephanie Poulain, MD, Stephen Harding, MD, PhD, Véronique Leblond, MD, PhD, Xavier Leleu, MD, PhD

Blood (2011) 118 (21): 2667.

https://doi.org/10.1182/blood.V118.21.2667.2667

Published: 2011

Journal Articles

SOCS1 and SOCS3 Genes Are Not Methylated In Waldenstrom Macroglobulinemia

Stephanie Poulain, Rachid Aijjou, Natacha Broucqsault, Salomon Manier, Sylvie Galiégue-Zouitina, Charles Herbaux, Sabine Tricot, Agnes Daudignon, Patrick Duthilleul, Christophe Roumier, Xavier Leleu, MD, PhD

Blood (2010) 116 (21): 2481.

https://doi.org/10.1182/blood.V116.21.2481.2481

Published: 2010

Journal Articles

A20 Gene Deregulation In Waldenstrom's Macroglobulinemia.

Stephanie Poulain, Rachid Aijjou, Natacha Broucqsault, Salomon Manier, Agnes Daudignon, Charles Herbaux, Sylvie Galiegue-Zouitina, Sabine Tricot, Patrick Duthilleul, Pierre Morel, Claude Preudhomme, Christophe Roumier, Xavier Leleu, MD, PhD

Blood (2010) 116 (21): 3628.

https://doi.org/10.1182/blood.V116.21.3628.3628

Published: 2010

Journal Articles

Evaluation of Chemotherapy-Induced Ovarian Failure by Sequential Anti-Müllerian Hormone Dosage.

Sabine Tricot, Christine Decanter, Julia Salleron, Louis Terriou, Daniela Robu, Catherine Lefebvre, Franck Morschhauser, MD, PhD

Blood (2010) 116 (21): 3813.

https://doi.org/10.1182/blood.V116.21.3813.3813

Published: 2010

NARROW

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naïve (TN) Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2 rearrangement

Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Results of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"

The Bendamustine Plus Rituximab Regimen Is Active and Safe in Previously Untreated Patients with Waldenström Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO)

TP53 Mutation in Waldenstrom Macroglobulinemia

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Can Assessment of Patient Monoclonal Immunoglobulins By Heavy/Light Analysis be Used to Assign Patient Responses Analogous to IMWG Response Criteria?

Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques

Genomic Landscape of CXCR4 Mutations in Waldenstrom's Macroglobulinemia

MYD88 L265P mutation in Waldenstrom macroglobulinemia

Genome Wide SNP Array (SNPa) Analysis Reveals Clonal Evolution During Clinical Course in Waldenstrom's Macroglobulinemia (WM)

MYD88 L265P Mutation in Waldenstrom's Macroglogulinemia

B-Cell-Specific Transcription Factor BACH2 Involved in the Clinical Behavior Heterogeneity of Waldenström Macroglobulinemia

90-Yttrium Ibritumomab Tiuxetan (Zevalin) and BEAM Chemotherapy (Z-BEAM) Vs BEAM for Autologous Stem Cell Transplantation in Lymphoma: Toxicity and Long Term Outcome From a Retrospective Multicentric Study of 123 Patients.

Hevylite, a Novel M-Component Based Biomarkers of Response to Therapy and Survival in Waldenstrom Macroglobulinemia

SOCS1 and SOCS3 Genes Are Not Methylated In Waldenstrom Macroglobulinemia

A20 Gene Deregulation In Waldenstrom's Macroglobulinemia.

Evaluation of Chemotherapy-Induced Ovarian Failure by Sequential Anti-Müllerian Hormone Dosage.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only